Vanguard Capital Management
TECH icon

Vanguard Capital Management’s Bio-Techne TECH Stock Holding History

Vanguard Capital Management’s Portfolio TECH Stock Details TECH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$722M Buy
10,218,558
+38,849
+0.4% +$2.1M 0.02% 586
2026
Q1 		$532M Buy
+10,179,709
New +$611M 0.01% 652

Other funds holding TECH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
RCG
Ruane, Cunniff & Goldfarb New York $6.43B AUM 18.44% 1-Year Est. Return
SCM
Snyder Capital Management San Francisco, California $5.79B AUM 33.56% 1-Year Est. Return

Vanguard Capital Management's TECH Position: Q2 2026 in Review

Vanguard Capital Management increased its Bio-Techne (TECH) stake by 0.38% in Q2 2026, buying an estimated $2.1M and bringing the position to 10,218,558 shares worth $722M. The position accounts for 0.02% of the portfolio, ranked #586.

Vanguard Capital Management first reported a position in TECH in Q1 2026 and has held it in 2 quarters since. 560 funds tracked by Wall St. Rank hold TECH as of Q2 2026.

  • Vanguard Capital Management held 10,218,558 shares of Bio-Techne worth $722M as of Q2 2026.
  • Vanguard Capital Management bought 38,849 Bio-Techne shares in Q2 2026, an estimated $2.1M.
  • Bio-Techne made up 0.02% of Vanguard Capital Management's portfolio in Q2 2026, its #586 holding.
  • Vanguard Capital Management first reported a position in Bio-Techne in Q1 2026 and has held it in 2 quarters since.
  • 560 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2026.

Based on Vanguard Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.